TIDMCLIN
RNS Number : 5383U
JPMorgan Securities Plc
03 December 2021
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH
RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING
CAPACITY
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Name of exempt principal trader: J.P. Morgan Securities Plc
(b) Name of offeror/offeree in relation to whose relevant Clinigen Group plc
securities this form relates:
Use a separate form for each offeror/offeree
--------------------------------------------------
(c) Name of the party to the offer with which exempt principal financial adviser to Triton Investment Management
trader is connected:
--------------------------------------------------
(d) Date dealing undertaken: 2 December 2021
--------------------------------------------------
(e) In addition to the company in 1(b) above, is the exempt N/A
principal trader making disclosures
in respect of any other party to this offer?
If it is a cash offer or possible cash offer, state "N/A"
--------------------------------------------------
2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of
relevant securities of the offeror or offeree named in 1(b), copy
table 2(a), (b), (c) or (d) (as appropriate) for each additional
class of relevant security dealt in.
The currency of all prices and other monetary amounts should be
stated.
(a) Purchases and sales
Class of relevant Purchases/ sales Total number of Highest price per unit Lowest price per unit
security securities paid/received paid/received
0.1p ordinary Purchase 1,588,946 7.9191 GBP 6.1700 GBP
Sale 974,896 7.8705 GBP 6.1922 GBP
----------------- ------------------------ ----------------------- -----------------------
(b) Cash-settled derivative transactions
Class of relevant Product description Nature of dealing Number of reference Price per unit
security e.g. CFD e.g. opening/closing a securities
long/short position,
increasing/reducing a
long/short position
0.1p ordinary Equity Swap Decrease Long 3,121 6.1990 GBP
15,146 6.8786 GBP
31,463 6.9306 GBP
71 7.0456 GBP
772 7.0881 GBP
9,173 7.1328 GBP
43,975 7.1436 GBP
4,351 7.1825 GBP
11,134 7.1832 GBP
9,584 7.3314 GBP
2,397 7.3506 GBP
3,405 7.3677 GBP
39,141 7.3993 GBP
58,002 7.4116 GBP
29,001 7.4544 GBP
125 7.4556 GBP
21,744 7.4844 GBP
3,655 7.4935 GBP
52 7.5001 GBP
55,440 7.5232 GBP
26,322 7.5969 GBP
9,295 7.6024 GBP
91,567 7.6183 GBP
38 7.7556 GBP
Decrease Short 1,933 6.1873 GBP
1,471 6.1993 GBP
2,155 6.2167 GBP
1,903 6.2184 GBP
9,975 6.2570 GBP
2,069 6.2758 GBP
8,249 6.3714 GBP
819 6.6103 GBP
14,098 7.0510 GBP
1,538 7.1132 GBP
2,727 7.1709 GBP
2,249 7.1713 GBP
507 7.2275 GBP
4,250 7.3389 GBP
127,250 7.4324 GBP
8,360 7.7411 GBP
387 7.7842 GBP
48,386 7.7850 GBP
Increase Long 469 6.2049 GBP
4,364 6.2231 GBP
2,612 6.2247 GBP
956 6.2383 GBP
1,046 6.2398 GBP
12,517 6.6784 GBP
34 6.7238 GBP
37,555 7.1490 GBP
34,737 7.2766 GBP
11,179 7.3343 GBP
2,200 7.7232 GBP
5,065 7.7591 GBP
48,866 7.7850 GBP
Increase Short 6,568 6.2073 GBP
14,590 6.2093 GBP
43 6.2187 GBP
1,326 6.2636 GBP
22,000 6.3442 GBP
7,192 6.4566 GBP
2,618 6.4817 GBP
750 6.5102 GBP
154 6.5702 GBP
874 6.6199 GBP
1,598 6.7780 GBP
300 7.1055 GBP
1,885 7.2055 GBP
3,142 7.3361 GBP
70,000 7.3734 GBP
15,979 7.3760 GBP
63,939 7.4127 GBP
191 7.4451 GBP
565 7.4965 GBP
200,000 7.5038 GBP
836 7.5050 GBP
1,917 7.5054 GBP
8,360 7.5940 GBP
5,098 7.6236 GBP
468 7.6954 GBP
66,650 7.7715 GBP
19,970 7.7850 GBP
1 7.7852 GBP
22,027 7.7854 GBP
4,927 7.7953 GBP
48,941 7.8054 GBP
Opening a Long Position 15,000 6.6529 GBP
50,000 6.6598 GBP
Opening a Short Position 15,000 6.4372 GBP
1,967 7.7874 GBP
-------------------- ------------------------- ------------------------- ---------------
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Type Expiry date Option money
relevant description purchasing, securities price per e.g. paid/
security e.g. call selling, to which unit American, received per
option varying etc. option European unit
relates etc.
(ii) Exercise
Class of relevant Product description Exercising/ exercised Number of securities Exercise price per
security e.g. call option against unit
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable)
e.g. subscription, conversion
3. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal
or informal, relating to relevant securities which may be an inducement to deal or refrain
from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such
agreements, arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the exempt
principal trader making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which
any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
None
Date of disclosure: 3 December 2021
Contact name: Alwyn Basch
----------------
Telephone number: 020 7742 7407
----------------
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service.
The Panel's Market Surveillance Unit is available for
consultation in relation to the Code's dealing disclosure
requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
FERDKNBNDBDDDBK
(END) Dow Jones Newswires
December 03, 2021 06:32 ET (11:32 GMT)
Clinigen (LSE:CLIN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Clinigen (LSE:CLIN)
Historical Stock Chart
From Jul 2023 to Jul 2024
